The EPS projection of Amedisys Inc (NASDAQ:AMED) for quarter ended 2016-09-30 is $0.47. Last week, the projection for EPS was $0.47 against target of $0.47, a month earlier. While 2-months ago, this projection was $0.47 versus forecast of $0.47a quarter months earlier, posting a deviation of 0%.
Amedisys Inc (NASDAQ:AMED) posted that 18 days earlier, the share price was revised 4 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 1 and 1. While in last 120 and 90 days, positive revisions were 2, and 2, correspondingly.
The per-share earnings downgrade for Amedisys Inc (NASDAQ:AMED) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Amedisys Inc (NASDAQ:AMED) EPS target was $0.47 for the quarter closed 1. It was based on 6 calls. As on 2016-05-03 the EPS was $0.33. The change was $-0.01, posting a deviation of -2.94%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Amedisys Inc (NASDAQ:AMED) sales prediction for the fiscal 2017 stands at $383.706 and the median estimate is at $383.973. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $388.58 while the lowest target is $378.3 showing standard deviation of 4.307%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of 0.488%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...